Martinotti Giovanni, Santacroce Rita, Pettorruso Mauro, Montemitro Chiara, Spano Maria Chiara, Lorusso Marco, di Giannantonio Massimo, Lerner Arturo G
Department of Neuroscience, Imaging and Clinical Sciences, University "G. d'Annunzio", 66100 Chieti, Italy.
Department of Pharmacy, Pharmacology, Postgraduate Medicine, University of Hertfordshire, Herts AL10 9AB, UK.
Brain Sci. 2018 Mar 16;8(3):47. doi: 10.3390/brainsci8030047.
Hallucinogen Persisting Perception Disorder (HPPD) is a rare, and therefore, poorly understood condition linked to hallucinogenic drugs consumption. The prevalence of this disorder is low; the condition is more often diagnosed in individuals with a history of previous psychological issues or substance misuse, but it can arise in anyone, even after a single exposure to triggering drugs. The aims of the present study are to review all the original studies about HPPD in order to evaluate the following: (1) the possible suggested etiologies; (2) the possible hallucinogens involved in HPPD induction; (3) the clinical features of both HPPD I and II; (4) the possible psychiatric comorbidities; and (5) the available and potential therapeutic strategies. We searched PubMed to identify original studies about psychedelics and Hallucinogen Persisting Perception Disorder (HPPD). Our research yielded a total of 45 papers, which have been analyzed and tabled to provide readers with the most updated and comprehensive literature review about the clinical features and treatment options for HPPD.
致幻剂持续性感知障碍(HPPD)是一种罕见的、因此人们了解甚少的与使用致幻药物相关的病症。这种障碍的患病率很低;该病症在既往有心理问题或药物滥用史的个体中更常被诊断出来,但任何人都可能出现,即使是在单次接触引发药物之后。本研究的目的是回顾所有关于HPPD的原始研究,以便评估以下内容:(1)可能的病因;(2)可能参与引发HPPD的致幻剂;(3)HPPD I型和II型的临床特征;(4)可能的精神共病;以及(5)现有的和潜在的治疗策略。我们在PubMed上搜索以识别关于迷幻剂和致幻剂持续性感知障碍(HPPD)的原始研究。我们的研究共产生了45篇论文,这些论文已被分析并制成表格,为读者提供关于HPPD临床特征和治疗选择的最新、最全面的文献综述。